Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Barr Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?

BARR has one hundred and seventy-five approved drugs.

There are seven tentative approvals on BARR drugs.

Summary for Barr
US Patents:0
Patent Litigation for Barr: See patent lawsuits for Barr

Drugs and US Patents for Barr

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr HYDROCODONE BITARTRATE AND ACETAMINOPHEN acetaminophen; hydrocodone bitartrate TABLET;ORAL 088577-001 Dec 21, 1984 DISCN No No   Start Trial   Start Trial
Barr AMINOPHYLLINE aminophylline TABLET;ORAL 088297-001 Aug 19, 1983 DISCN No No   Start Trial   Start Trial
Barr ESTRADIOL AND NORGESTIMATE estradiol; norgestimate TABLET;ORAL 076812-001 Apr 29, 2005 RX No Yes   Start Trial   Start Trial
Barr Labs Inc TRETINOIN tretinoin CAPSULE;ORAL 077684-001 Jun 22, 2007 AB RX No Yes   Start Trial   Start Trial
Barr METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET;ORAL 075971-001 Jan 25, 2002 DISCN No No   Start Trial   Start Trial
Barr Labs Inc CHLORTHALIDONE chlorthalidone TABLET;ORAL 088902-001 Sep 19, 1985 DISCN No No   Start Trial   Start Trial
Barr TREXALL methotrexate sodium TABLET;ORAL 040385-004 Mar 21, 2001 RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.